Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) widely prescribed for major depressive disorder, generalised anxiety disorder and panic disorder, with dose-dependent dual-neurotransmitter activity. Simson Pharma's Venlafaxine reference standard and impurities support the high-volume compendial and stability-indicating testing this widely prescribed antidepressant requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Venlafaxine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.